Soterix Medical Inc. (SMI) was formed to develop and deploy innovative medical treatments focused on neuropsychiatric and neurological disorders and rehabilitation. Founded in 2008, SMI is the world leader in clinical trials for non-invasive neuromodulation working with over 250 medical centers in the US and worldwide. SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. Ongoing Phase I, II, IIb, and III trials use investigational devices that are regulated/limited by US or Federal law. SMI is proudly based in New York City with international distributors in all major markets.

Engineering Serving Humanity

At Soterix Medical, Engineering Serving Humanity means that we are committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.

From the NIH website: ”Stroke survivors are often left with residual motor dysfunction, which despite the best-known care,results in substantial personal, social and economic cost.We suggest that Transcranial Direct Current Stimulation (tDCS) delivered prior to robotic motor training will improve clinical function when performed over 12 weeks of training. We propose to test cortical neurophysiology and kinematic changes in relation to improved clinical function to report the specific aspects of movement control that are enhanced, and the underlying brain plasticity. This will help understand the physiological and behavioral aspects of this emerging rehabilitation strategy, and may be useful to guide clinical trials for optimizing motor recovery in stroke, and ultimately to have broader application to other neurological disorders.”

Abhishek Datta, CTO of Soterix Medical summarizes “The Soterix Medical 1x1 tDCS device and accessories are the most advanced and controlled platform for direct current delivered as an adjunct to rehabilitation. Soterix Medical has established relationship with international leading centers such as Burke Medical Research Institute and Burke Rehabilitation Hospital where Prof. Dylan Edwards is leading the most systematic analysis of tDCS for this indication to date. For large studies requiring consistent preparation, the Soterix EASYpads provide un-paralleled reproducibility, while the set-up and fit of the EASYpads allow simple and reliable fixation of the EASYpads to the scalp. ”

At Soterix Medical Inc., Engineering Serving Humanity means that we're committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.